Kaytan Sağlam E - Search Results

1

Outcomes of thymoma after multimodal therapy and determinants of survival: A 16-year experience of a tertiary cancer center.

Ak N, Toker A, Kara M, Özkan B, Ülker M, Kaba E, Yeğen G, Karaman Ş, Dağoğlu N, Kaytan Sağlam E, Oral EN, Kızır A, Bayraktar S, Dişçi R, Ferhatoğlu F, Aydın E, Vatansever S, Eralp Y, Aydıner A. Ak N, et al. Among authors: kaytan saglam e. Turk Gogus Kalp Damar Cerrahisi Derg. 2021 Oct 20;29(4):487-495. doi: 10.5606/tgkdc.dergisi.2021.20529. eCollection 2021 Oct. Turk Gogus Kalp Damar Cerrahisi Derg. 2021. PMID: 35096446 Free PMC article.

2

Paraoxonase-1 192/55 polymorphisms and the risk of lung cancer in a Turkish population.

Aksoy-Sagirli P, Cakmakoglu B, Isbir T, Kaytan-Saglam E, Kizir A, Topuz E, Berkkan H. Aksoy-Sagirli P, et al. Among authors: kaytan saglam e. Anticancer Res. 2011 Jun;31(6):2225-9. Anticancer Res. 2011. PMID: 21737645

3

Adjuvant chemoradiotherapy after D2 resection in gastric cancer: a single-center observational study.

Kaytan Saglam E, Yucel S, Balik E, Saglam S, Asoglu O, Yamaner S, Bugra D, Oral EN, Kizir A, Kapran Y, Sakar B, Akyuz A, Gulluoglu M. Kaytan Saglam E, et al. Among authors: saglam s. J Cancer Res Clin Oncol. 2015 Feb;141(2):361-7. doi: 10.1007/s00432-014-1816-y. Epub 2014 Sep 5. J Cancer Res Clin Oncol. 2015. PMID: 25189794 Clinical Trial.

4

Association of Three Single Nucleotide Polymorphisms in MTR and MTRR Genes with Lung Cancer in a Turkish Population.

Aksoy-Sagirli P, Erdenay A, Kaytan-Saglam E, Kizir A. Aksoy-Sagirli P, et al. Among authors: kaytan saglam e. Genet Test Mol Biomarkers. 2017 Jul;21(7):428-432. doi: 10.1089/gtmb.2017.0062. Epub 2017 May 24. Genet Test Mol Biomarkers. 2017. PMID: 28537809

5

Neoadjuvant hyperfractionated accelerated radiotherapy plus concomitant 5-fluorouracil infusion in locally advanced rectal cancer: A phase II study.

Gural Z, Saglam S, Yucel S, Kaytan-Saglam E, Asoglu O, Ordu C, Acun H, Sharifov R, Onder S, Kizir A, Oral EN. Gural Z, et al. Among authors: kaytan saglam e. World J Gastrointest Oncol. 2018 Jan 15;10(1):40-47. doi: 10.4251/wjgo.v10.i1.40. World J Gastrointest Oncol. 2018. PMID: 29375747 Free PMC article.

6

The Impact of Primary Tumor and Locoregional Metastatic Lymph Node SUV_max on Predicting Survival in Patients with Rectal Cancer.

Alçın G, Şanlı Y, Yeğen G, Kaytan Sağlam E, Çermik TF. Alçın G, et al. Among authors: kaytan saglam e. Mol Imaging Radionucl Ther. 2020 Apr 29;29(2):65-71. doi: 10.4274/mirt.galenos.2020.40316. Mol Imaging Radionucl Ther. 2020. PMID: 32368877 Free PMC article.

7

Prognostic significance of early complete response in patients with locally advanced rectal cancer undergoing preoperative chemoradiotherapy: Multicentric study of Turkish Society for Radiation Oncology Group (TROD).

Kılıç D, Sert F, Görken İB, Arıcan Alıcıkuş Z, Aktürk N, Kaytan Sağlam E, Kizir A, Özkök S, Yılmaz HT, Göçen F, Yalman D. Kılıç D, et al. Among authors: kaytan saglam e. Turk J Gastroenterol. 2020 May;31(5):368-377. doi: 10.5152/tjg.2020.19225. Turk J Gastroenterol. 2020. PMID: 32519956 Free PMC article.

8

Prognostic factors in medically inoperable early stage lung cancer patients treated with stereotactic ablative radiation therapy (SABR): Turkish Radiation Oncology Society Multicentric Study.

Sahin B, Atalar B, Kaytan Saglam E, Akgun Z, Abacioglu U, Arifoglu A, Ozyar E, Yaprak G, Ozseker Isik N, Guney Y, Caglar HB, Karaman S, Igdem S, Selek U, Berber T, Oner Dincbas F, Sengoz M, Yucel S, Demiral AN, Akyurek S. Sahin B, et al. Among authors: kaytan saglam e. Clin Respir J. 2020 Nov;14(11):1050-1059. doi: 10.1111/crj.13240. Epub 2020 Aug 17. Clin Respir J. 2020. PMID: 32749053

9

The correlates of benefit from neoadjuvant chemotherapy before surgery in non-small-cell lung cancer: a metaregression analysis.

Bozcuk H, Abali H, Coskun S; Lung Cancer Committee of Turkish Oncology Group. Bozcuk H, et al. World J Surg Oncol. 2012 Aug 9;10(1):161. doi: 10.1186/1477-7819-10-161. World J Surg Oncol. 2012. PMID: 22877422 Free PMC article.

10

Neoadjuvant chronomodulated capecitabine with radiotherapy in rectal cancer: a phase II brunch regimen study.

Akgun Z, Saglam S, Yucel S, Gural Z, Balik E, Cipe G, Yildiz S, Kilickap S, Okyar A, Kaytan-Saglam E. Akgun Z, et al. Among authors: kaytan saglam e, saglam s. Cancer Chemother Pharmacol. 2014 Oct;74(4):751-6. doi: 10.1007/s00280-014-2558-x. Epub 2014 Aug 8. Cancer Chemother Pharmacol. 2014. PMID: 25102935 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page